返回 Agenda
SLS04 Scientific Benefit-Risk Management and Communication for the Future
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor, Department of Clinical Medicine (Pharmaceutical Medicine)
Kitasato University School of Pharmacy , Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Juan Garcia-Burgos, MD, PhD
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
Kazuhiko Ishida, MSc, RPh
Astellas Pharma Inc., Japan
Director, Pharmacovigilance